![](/img/cover-not-exists.png)
187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS
P. Phatak, P. Brissot, M. Wurster, P.C. Adams, H.L. Bonkovsky, J. Gross, P. Malfertheiner, G.D. McLaren, C. Niederau, A. Piperno, L.W. Powell, M. Russo, U. Stoelzel, W. Stremmel, L. Griffel, N. Lynch,Volume:
52
Year:
2010
Language:
english
DOI:
10.1016/s0168-8278(10)60189-4
File:
PDF, 54 KB
english, 2010